IL6 and neoplasm: Activation of tumor-specific IL-6, a target of the CSC-regulating pathway molecule YAP1 (7), in the tumor cells induces the expression of PD-L1 (10), and we previously reported that YAP1 regulates CSC generation and expansion in UCB (6).